Cristina S.
- Country
- Spain
- Department
- Gastroenterology
Research Overview
- Phase I Study of XL092 Monotherapy and Combination Therapy in Advanced Solid Tumors: ccRCC, nccRCC, HR+ BC, mCRPC, and CRC
- Phase 1 Evaluation of AB521 Monotherapy and Combination Therapies in Patients with Clear Cell Renal Cell Carcinoma and Other Solid Tumors
- Evaluation of RO7566802 Monotherapy and Combination with Atezolizumab in Locally Advanced or Metastatic Solid Tumor Malignancies
Data & Insights
Has run more than one trial at 160 of 364 partner sites.
Specializations
Oncology Research
Specializes in investigating innovative treatments for papillary renal cell carcinoma (PRCC), with particular emphasis on advanced and metastatic cases.
- MET-driven renal cancers
- Unresectable renal tumors
- Advanced stage kidney cancer
Focuses on evaluating therapeutic approaches for patients with locally advanced or metastatic kidney cancer.
Targeted Therapy
Investigates the effectiveness of targeted therapeutic agents in MET-driven cancers, specifically examining novel treatment combinations for renal malignancies.
- Combination therapy approaches
- MET pathway inhibition
- Targeted treatment strategies
Explores innovative therapeutic combinations to enhance treatment outcomes in advanced kidney cancer.
Clinical Outcomes
Evaluates progression-free survival in patients with advanced renal cancer, focusing on comparative effectiveness of different treatment approaches.
- Treatment effectiveness assessment
- Survival outcomes
- Clinical response evaluation
Specializes in analyzing therapeutic efficacy in advanced renal malignancies.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.